Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Autoantibodies in sera of pancreatic cancer patients identify recombination factor Rad51 as a tumour-associated antigen

1 Apr 2002

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
T-cell and B-cell Immunology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 11935313
DOI: 10.1007/s00432-001-0321-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Autoantibodies in sera of pancreatic cancer patients identify recombination factor Rad51 as a tumour-associated antigenPMID 11935313Read ↗

RAD51 as a potential biomarker and therapeutic target for pancreatic cancerSemantic proximity Read ↗

RAD51 as a potential surrogate marker for DNA repair capacity in solid malignanciesSemantic proximity Read ↗

RAD51 is a potential marker for prognosis and regulates cell proliferation in pancreatic cancerSemantic proximity Read ↗

Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response proteinSemantic proximity Read ↗

A Pan-Cancer Bioinformatic Analysis of RAD51 Regarding the Values for Diagnosis, Prognosis, and Therapeutic PredictionSemantic proximity Read ↗

Variation in RAD51 details a hub of functions: opportunities to advance cancer diagnosis and therapySemantic proximity Read ↗

Targeting RAD51-Mediated Homologous Recombination as a Treatment for Advanced Solid and Hematologic Malignancies: Opportunities and Challenges AheadSemantic proximity Read ↗

High RAD51 Gene Expression is Associated with Aggressive Biology and with Poor Survival in Breast CancerSemantic proximity Read ↗

Cancer mutations in RAD51 and its paralogues.Semantic proximity Read ↗

The RAD51 gene family, genetic instability and cancer.Semantic proximity Read ↗

Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cellsSemantic proximity Read ↗

Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.